Press "esc" to clear
Go to Advanced Search

Showing results

110 of 1167
WithLinks_Closer.jpg
  • Embargo expired:
    13-Aug-2018 12:00 AM EDT

Article ID: 698850

For the 50 Million

American Autoimmune Related Diseases Association (AARDA)

7th DC Metro Autoimmune Walk -- Linking Together for a Cure

Released:
10-Aug-2018 6:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 698742

This small molecule could hold the key to promising HIV treatments

Cornell University

New research provides details of how the structure of the HIV-1 virus is assembled, findings that offer potential new targets for treatment.

Released:
8-Aug-2018 5:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
  • Embargo expired:
    7-Aug-2018 10:00 AM EDT

Article ID: 698229

New Method Helps Determine Effectiveness of Interventions in Reducing Spread of HIV

New York University

Using genetic sequencing to understand the evolutionary relationships among pathogens, an international team of researchers—including several from the Center for Drug Use and HIV/HCV Research (CDUHR) at New York University—has developed a new method to determine how effective interventions are against the spread of infectious diseases like HIV.

Released:
30-Jul-2018 1:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Blood_Test_HIV_iStock-611890522.jpg

Article ID: 698612

Researchers Uncover Potential New Drug Targets in the Fight Against HIV

Johns Hopkins Medicine

Johns Hopkins scientists report they have identified two potential new drug targets for the treatment of HIV. The finding is from results of a small, preliminary study of 19 people infected with both HIV—the virus that causes AIDS—and the hepatitis C virus. The study revealed that two genes—CMPK2 and BCLG, are selectively activated in the presence of type 1 interferon, a drug once used as the first line of treatment against hepatitis C.

Released:
7-Aug-2018 8:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
RS19058_IsabelScarinci-4-scr1.jpg

Article ID: 698532

Mobilizing the HPV vaccine

University of Alabama at Birmingham

Released:
3-Aug-2018 11:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Thomas-nr-r.jpg

Article ID: 698391

Computer simulations predict the spread of HIV

Los Alamos National Laboratory

In a recently published study in the journal Nature Microbiology, researchers at Los Alamos National Laboratory show that computer simulations can accurately predict the transmission of HIV across populations, which could aid in preventing the disease.

Released:
1-Aug-2018 12:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 698327

Wolters Kluwer and the Association of Nurses in AIDS Care Announce Publishing Partnership

Wolters Kluwer Health: Lippincott Williams and Wilkins

Wolters Kluwer Health announced today it will begin publishing The Journal of the Association of Nurses in AIDS Care from the Association of Nurses in AIDS Care (ANAC). Under the new partnership, Wolters Kluwer will publish the clinical and scientific journal in its Lippincott Portfolio beginning January 2019.

Released:
31-Jul-2018 11:45 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
logo-ortho-clinical-diagnostics-black.jpg

Article ID: 698285

FDA Approves Ortho Clinical Diagnostics VITROS® Immunodiagnostic Products HIV Combo Reagent Pack and Calibrator on the VITROS® 3600 Immunodiagnostic System

70th AACC Annual Scientific Meeting Press Program

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced that its VITROS Immunodiagnostic Products HIV Combo Reagent Pack and Calibrator (VITROS® HIV Combo test) received approval from the U.S. Food and Drug Administration for use on Ortho’s VITROS 3600 Immunodiagnostic System

Released:
30-Jul-2018 5:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
researchbriefheaderideas2018.07rev2.jpg

Article ID: 698117

BIDMC Research Brief Digest: July 2018

Beth Israel Deaconess Medical Center

A monthly roundup of research briefs showcasing recent scientific advances led by Beth Israel Deaconess Medical Center faculty.

Released:
26-Jul-2018 3:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 697910

US Department of State, UVA Darden and Concordia Announce Finalists for 2018 P3 Impact Award

University of Virginia Darden School of Business

Finalists for the 2018 P3 Impact Award were announced by the Office of Global Partnerships at the U.S. Department of State, the University of Virginia Darden School of Business Institute for Business in Society and Concordia. The award recognizes exemplary public-private partnerships (P3s) that provide solutions to pressing issues in areas such as: economic development, housing, health and sanitation, and workforce.

Released:
25-Jul-2018 8:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Law and Public Policy


Showing results

110 of 1167





Chat now!